Economic analysis of medical pharmaceutical distribution

2015 Fiscal Year Final Research Report

• Project/Area Number: 25380317
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Research Field: Economic policy
• Research Institution: Atomi University
• Principal Investigator: Tanno Tadanobu 跡見学園女子大学, マネジメント学部, 准教授 (40282933)
• Co-Investigator(Kenkyū-buntansha): YAMADA Akira 札幌大学, 地域共創学群, 教授 (50364203) ; SAKURAI Hidehiko 北海道薬科大学, 薬学部, 教授 (70326560) ; HAYASHI Yukinari 広島国際大学, 医療経営学部, 教授 (90389122)
• Project Period (FY): 2013-04-01 – 2016-03-31
• Keywords: 医療用医薬品 / 流通 / 交渉力 / 薬価

Outline of Final Research Achievements

To obtain a qualitative results about how to affect the profit of the upstream pharmaceutical manufacturer by the difference in bargaining power between the pharmaceutical wholesaler and medical institution in the theory part. Under the current drug pricing system bargaining power is higher upstream pharmaceutical manufacturer profit of wholesale increases. The main conclusion by empirical analysis, the probability of the total value traded the larger the scale of hospitals and pharmacies is that the increases. On the other hand, the probability that the number of wholesale to trade shifts to the single item unit price traded higher utilization rate of more or generic drugs is higher.
Four ethical pharmaceutical wholesale offers a variety of information to the upstream pharmaceutical manufacturers, it was revealed that its consideration has become a source of big profits.

Free Research Field

産業組織論